106 related articles for article (PubMed ID: 20142546)
1. Expression of vascular endothelial growth factor in retinoblastoma.
Areán C; Orellana ME; Abourbih D; Abreu C; Pifano I; Burnier MN
Arch Ophthalmol; 2010 Feb; 128(2):223-9. PubMed ID: 20142546
[TBL] [Abstract][Full Text] [Related]
2. [HIF-1alpha, HPSE and VEGF promote malignant progression of retinoblastoma].
Wang XL; Niu YJ; Ma JM
Zhonghua Yan Ke Za Zhi; 2010 Feb; 46(2):140-4. PubMed ID: 20388348
[TBL] [Abstract][Full Text] [Related]
3. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma.
Jia RB; Zhang P; Zhou YX; Song X; Liu HY; Wang LZ; Luo M; Lu J; Ge SF; Fan XQ
Ophthalmic Res; 2007; 39(2):108-15. PubMed ID: 17284938
[TBL] [Abstract][Full Text] [Related]
4. Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2.
Garcia JR; Gombos DS; Prospero CM; Ganapathy A; Penland RL; Chévez-Barrios P
Arch Pathol Lab Med; 2015 Dec; 139(12):1531-8. PubMed ID: 26619025
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between vasculogenic mimicry and clinical pathological characters in retinoblastoma].
Niu YJ; Liu FL; Yang Y; Yuan CY
Zhonghua Yan Ke Za Zhi; 2009 Apr; 45(4):318-22. PubMed ID: 19575963
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment].
Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD
Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of bevacizumab on the angiogenesis and growth of retinoblastoma.
Lee SY; Kim DK; Cho JH; Koh JY; Yoon YH
Arch Ophthalmol; 2008 Jul; 126(7):953-8. PubMed ID: 18625942
[TBL] [Abstract][Full Text] [Related]
8. Higher vessel densities in retinoblastoma with local invasive growth and metastasis.
Rössler J; Dietrich T; Pavlakovic H; Schweigerer L; Havers W; Schüler A; Bornfeld N; Schilling H
Am J Pathol; 2004 Feb; 164(2):391-4. PubMed ID: 14742245
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
[TBL] [Abstract][Full Text] [Related]
10. Clinical pathologic study of a cohort of patients with retinoblastoma from a developing country.
Orellana ME; Fernandes BF; Arean C; Pifano I; Al-Kandari A; Burnier MN
J Pediatr Ophthalmol Strabismus; 2009; 46(5):294-9. PubMed ID: 19791727
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of CD117 and vascular endothelial growth factor in retinoblastoma: possible targets of new therapies.
Youssef NS; Said AM
Int J Clin Exp Pathol; 2014; 7(9):5725-37. PubMed ID: 25337214
[TBL] [Abstract][Full Text] [Related]
12. Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma.
Marback EF; Arias VE; Paranhos A; Soares FA; Murphree AL; Erwenne CM
Br J Ophthalmol; 2003 Oct; 87(10):1224-8. PubMed ID: 14507753
[TBL] [Abstract][Full Text] [Related]
13. Leucine-Rich α-2-Glycoprotein-1 (LRG-1) Expression in Retinoblastoma.
Amer R; Tiosano L; Pe'er J
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):685-692. PubMed ID: 29392314
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.
Jockovich ME; Suarez F; Alegret A; Piña Y; Hayden B; Cebulla C; Feuer W; Murray TG
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5371-6. PubMed ID: 18055783
[TBL] [Abstract][Full Text] [Related]
15. Comparison of staging systems for extraocular retinoblastoma: analysis of 533 patients.
Chantada GL; Sampor C; Bosaleh A; Solernou V; Fandiño A; de Dávila MT
JAMA Ophthalmol; 2013 Sep; 131(9):1127-34. PubMed ID: 23787805
[TBL] [Abstract][Full Text] [Related]
16. Histopathological features and P-glycoprotein expression in retinoblastoma.
Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhancement of the anterior eye segment in patients with retinoblastoma: correlation between clinical, MR imaging, and histopathologic findings.
de Graaf P; van der Valk P; Moll AC; Imhof SM; Schouten-van Meeteren AY; Knol DL; Castelijns JA
AJNR Am J Neuroradiol; 2010 Feb; 31(2):237-45. PubMed ID: 19833805
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous tumor vasculature in retinoblastoma: implications for vessel targeting therapy.
Jockovich ME; Piña Y; Alegret A; Cebulla C; Feuer W; Murray TG
Retina; 2008 Mar; 28(3 Suppl):S81-6. PubMed ID: 18317352
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of angiogenesis associated factors of retinoblastoma cell line and tumor tissues].
Wu JH; Xu P; Yi MY; Wang F; Wang XL; Huang Q
Zhonghua Yan Ke Za Zhi; 2005 May; 41(5):419-22. PubMed ID: 15938806
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of proliferation, apoptosis, and angiogenesis in retinoblastoma and their association with the clinicopathologic parameters.
Kerimoğglu H; Kiratli H; Dinçtürk AA; Söylemezoğlu F; Bilgiç S
Jpn J Ophthalmol; 2003; 47(6):565-71. PubMed ID: 14636846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
